Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Operational Update June 4, 2025 Next Post Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute June 4, 2025 Related Posts Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 6, 2025 Prismo Metals Appoints Gordon Aldcorn as President June 6, 2025 Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025
Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 6, 2025
